{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:14:42Z","timestamp":1750220082662,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":19,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,21]]},"DOI":"10.1145\/3523286.3524506","type":"proceedings-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T22:26:24Z","timestamp":1654035984000},"page":"19-22","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer drug toxicity prediction Based on AdaBoost Extremely Random Tree"],"prefix":"10.1145","author":[{"given":"Ziyue","family":"Fan","sequence":"first","affiliation":[{"name":"Sun Yat-sen University, China"}]},{"given":"Shuyue","family":"Wang","sequence":"additional","affiliation":[{"name":"China University of Geosciences, China"}]},{"given":"Zhijun","family":"Li","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University, China"}]},{"given":"Zhongsui","family":"Xie","sequence":"additional","affiliation":[{"name":"Sun Yat-sen University, China"}]}],"member":"320","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"e_1_3_2_1_1_1","volume-title":"Global cancer statistics","author":"Torre L. A.","year":"2015","unstructured":"Torre , L. A. , Bray , F. , Siegel , R. L. , Ferlay , J. , Lortet\u2010Tieulent , J. , and Jemal , A . ( 2015 ). Global cancer statistics , 2012. CA : a cancer journal for clinicians, 65(2), 87-108. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet\u2010Tieulent, J., and Jemal, A. (2015). Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65(2), 87-108."},{"key":"e_1_3_2_1_2_1","volume-title":"Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1. Cancer letters, 440, 54-63","author":"Ding J.","year":"2019","unstructured":"Ding , J. , Wang , X. , Zhang , Y. , Sang , X. , Yi , J. , Liu , C. , Liu , Z. , Wang , M. , Zhang , N. , and Xue , Y . ( 2019 ). Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1. Cancer letters, 440, 54-63 . Ding, J., Wang, X., Zhang, Y., Sang, X., Yi, J., Liu, C., Liu, Z., Wang, M., Zhang, N., and Xue, Y. (2019). Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K\u03b1 inhibition through the transcriptional regulation of ER\u03b1. Cancer letters, 440, 54-63."},{"key":"e_1_3_2_1_3_1","volume-title":"Computer aided drug design: success and limitations. Current pharmaceutical design, 22(5), 572-581","author":"Hassan Baig M.","year":"2016","unstructured":"Hassan Baig , M. , Ahmad , K. , Roy , S. , Mohammad Ashraf , J. , Adil , M. , Haris Siddiqui , M. , Khan , S. , Amjad Kamal , M. , Provazn\u00edk , I. , and Choi , I . ( 2016 ). Computer aided drug design: success and limitations. Current pharmaceutical design, 22(5), 572-581 . Hassan Baig, M., Ahmad, K., Roy, S., Mohammad Ashraf, J., Adil, M., Haris Siddiqui, M., Khan, S., Amjad Kamal, M., Provazn\u00edk, I., and Choi, I. (2016). Computer aided drug design: success and limitations. Current pharmaceutical design, 22(5), 572-581."},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-009-2035-4_8"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00385"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-018-0283-x"},{"key":"e_1_3_2_1_7_1","volume-title":"ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches. Molecular pharmaceutics, 13(8), 2855-2866","author":"Wang S.","year":"2016","unstructured":"Wang , S. , Sun , H. , Liu , H. , Li , D. , Li , Y. , and Hou , T . ( 2016 ). ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches. Molecular pharmaceutics, 13(8), 2855-2866 . Wang, S., Sun, H., Liu, H., Li, D., Li, Y., and Hou, T. (2016). ADMET evaluation in drug discovery. 16. Predicting hERG blockers by combining multiple pharmacophores and machine learning approaches. Molecular pharmaceutics, 13(8), 2855-2866."},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00104"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0050-3"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0210-0"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemolab.2019.103853"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci500747n"},{"key":"e_1_3_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b02187"},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010044"},{"issue":"7","key":"e_1_3_2_1_15_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd.2016.136","article-title":"Parsing clinical success rates","volume":"15","author":"Mullard A.","year":"2016","unstructured":"Mullard , A. ( 2016 ). Parsing clinical success rates . Nature Reviews Drug Discovery , 15 ( 7 ), 447 - 448 . Mullard, A. (2016). Parsing clinical success rates. Nature Reviews Drug Discovery, 15(7), 447-448.","journal-title":"Nature Reviews Drug Discovery"},{"key":"e_1_3_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.184"},{"key":"e_1_3_2_1_17_1","volume-title":"Obstacles and opportunities in new drug development. Clinical pharmacology and therapeutics, 83(2), 210-212","author":"Kaitin K.","year":"2008","unstructured":"Kaitin , K. ( 2008 ). Obstacles and opportunities in new drug development. Clinical pharmacology and therapeutics, 83(2), 210-212 . Kaitin, K. (2008). Obstacles and opportunities in new drug development. Clinical pharmacology and therapeutics, 83(2), 210-212."},{"key":"e_1_3_2_1_18_1","volume-title":"Extremely randomized trees. Machine learning, 63(1), 3-42","author":"Geurts P.","year":"2006","unstructured":"Geurts , P. , Ernst , D. , and Wehenkel , L . ( 2006 ). Extremely randomized trees. Machine learning, 63(1), 3-42 . Geurts, P., Ernst, D., and Wehenkel, L. (2006). Extremely randomized trees. Machine learning, 63(1), 3-42."},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1006\/jcss.1997.1504"}],"event":{"name":"BIC 2022: 2022 2nd International Conference on Bioinformatics and Intelligent Computing","acronym":"BIC 2022","location":"Harbin China"},"container-title":["2022 2nd International Conference on Bioinformatics and Intelligent Computing"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3523286.3524506","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3523286.3524506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:09:30Z","timestamp":1750183770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3523286.3524506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":19,"alternative-id":["10.1145\/3523286.3524506","10.1145\/3523286"],"URL":"https:\/\/doi.org\/10.1145\/3523286.3524506","relation":{},"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"2022-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}